OPGN (OpGen, Inc.) Pangali Forward P/E
OpGen, Inc. (OPGN) is creating a digital environment to combat pathogens by integrating diagnostics with resistance data. The model relies on the installation of devices in clinics, which guarantees a steady sale of consumables. However, a shortage of funds has frozen the development of new products. The business's forward P/E reflects the dynamics of capital payback, where the 0.00 metric serves as the target level for assessing investment risks.
Ringkesan rincian data analitis OpGen Corporation (OPGN)
Professional managers utilize fundamental filters to identify assets with undervalued earnings growth potential. This metric compares the current market value of the stock with projected net income, which, combined with the recurring sales model for consumable cartridges of OpGen, Inc. (OPGN), allows for an assessment of future capitalization via the company's expected 12-month P/E.
